Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents for Diffuse Long Coronary Artery Disease

NCT02831205 is registered in ClinicalTrials.gov with Duk-Woo Park, MD as lead sponsor.

NCT NCT02831205
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02831205 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents for Diffuse Long Coronary Artery Disease
Lead sponsor
Duk-Woo Park, MD
Phase
Phase 4
Overall status
Terminated
Start date
July 31, 2016
Completion date
December 31, 2017
Enrollment
800 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

percutaneous transluminal coronary angioplasty